Leaving no one behind with immunisation

Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world's deadliest diseases.


About us Explore our Progress Report

Latest VaccinesWork features

View more

Finding invisible children in Congo-Brazzaville

In Congo-Brazzaville, children without birth certificates – and sometimes without vaccination cards – are still slipping through the cracks. In KM4, a neighbourhood of Pointe-Noire, nurses, community health workers and health committees are going…

Could a hantavirus vaccine be on the horizon?

A single shot of an experimental mRNA vaccine completely protected animals against the deadly Andes hantavirus, even at a fraction of the usual dose. 

Why Ebola outbreaks trigger extraordinary control measures

Ebola outbreaks trigger control measures that can feel intrusive, frightening or overly cautious. Here’s why.

VaccinesWork is an award-winning digital platform hosted by Gavi, covering news, features and explainers from every corner of global health and immunisation.

The Gavi Leap

The Gavi Leap

The Gavi Leap is the most ambitious reform agenda in global health, offering a blueprint for broader reform of the health and development architecture. Learn more about how Leap principles, such as country ownership, radical simplification and innovation, are already having a tangible impact on how immunisation is delivered in Gavi-supported countries.

The Gavi Leap

Our work

A mother with her child in Tanzania. Credit: Doune Porter

Vaccine portfolio

Gavi supports vaccines against 20 infectious diseases, including Ebola, malaria, mpox and rabies.

View our vaccines

A health worker in Tanzania. Credit: Gavi/2012/P Rudden

Health systems support

Strong health and immunisation systems are vital to deliver vaccines to all the children who need them.

Learn more

A health worker carrying vaccines in a cold box in Somalia. Credit: Gavi

Civil society support

We provide grants for civil society organisations (CSOs) working to reach zero-dose children and missed communities with vaccines.

Our work with CSOs

Gavi/2024/Mohamed Abdihakim Ali

Shaping vaccine markets

Working to improve the health of markets for vaccines and other immunisation products.

Learn more

Latest Gavi news releases

View all

Gavi statement on scaling innovative financing for the next pandemic

As part of its Gavi Leap reforms, Gavi remains committed to working with countries and partners to accelerate and strengthen coordination on pandemic financing.

Gavi statement on the Ebola disease outbreak in Democratic Republic of the Congo and Uganda

Gavi, the Vaccine Alliance is closely monitoring the Ebola disease outbreak caused by Bundibugyo virus that is currently affecting the Democratic Republic of the Congo (DRC) and Uganda.

The Vaccine Alliance

The Vaccine Alliance

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

The Vaccine Alliance

Gavi 6.0 funding guidelines

Newly released funding guidelines outline the scope of Gavi’s vaccine and cash support for the 2026–2030 strategic period (Gavi 6.0), explain how countries should plan and prioritise their immunisation programmes within this support, clarify the requirements for the Gavi 6.0 country application and describe how to access other forms of assistance such as outbreak and emergency support.

Access the guidelines

World Map

Partner countries

Partner countries

Since its inception in 2000, Gavi has helped to immunise a whole generation – over 1.2 billion children – and prevented more than 20.6 million future deaths, helping to halve child mortality in 78 lower‑income countries.

Our donors

Our donors

As a public-private partnership, Gavi is funded by governments, foundations, institutions, organisations, corporations and private individuals.

Global Summit 2025

>1.2 billion children vaccinated through routine programmes
>20.6 million future deaths averted
17 countries fully self-financing
>280 US$ billion in economic benefits for countries
2.1 billion vaccinations through preventive vaccination campaigns